A Retrospective, Observational, Noninterventional Data Collection Study for Patients With Molybdenum Cofactor Deficiency Who Have Been Previously Treated With Cyclic Pyranopterin Monophosphate (cPMP)

Trial Profile

A Retrospective, Observational, Noninterventional Data Collection Study for Patients With Molybdenum Cofactor Deficiency Who Have Been Previously Treated With Cyclic Pyranopterin Monophosphate (cPMP)

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Dec 2014

At a glance

  • Drugs Cyclic pyranopterin monophosphate (Primary)
  • Indications Molybdenum cofactor deficiency
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Alexion Pharmaceuticals
  • Most Recent Events

    • 07 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov
    • 17 Nov 2014 Planned number of patients changed from 11 to 15.
    • 17 Nov 2014 Planned End Date changed from 1 Mar 2014 to 1 Oct 2014.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top